The RAND Health Insurance Experiment: Moral Hazard Explained

Value-Based Insurance Design (VBID) is an approach to healthcare reform that recognizes not all medical services are equally valuable and adjusts insurance coverage accordingly to maximize health outcomes per dollar spent; instead of applying uniform cost-sharing to all services, VBID tailors financial incentives based on clinical evidence, such as offering free colorectal cancer screenings for high-risk individuals while charging full cost for low-risk patients, thereby encouraging appropriate healthcare utilization while containing costs.

Value-Based Insurance Design (V-BID) is a healthcare policy approach that aligns patient out-of-pocket costs with the clinical value of services, making high-value care more accessible (lower or no cost-sharing) while discouraging low-value care (higher cost-sharing). This approach addresses the problem of blunt consumer cost-sharing, where patients pay equally for all services regardless of clinical benefit, which disproportionately affects vulnerable populations and reduces access to essential care. V-BID has been successfully implemented in the Affordable Care Act's preventive services section, Medicare Advantage programs, and various state and federal initiatives, demonstrating bipartisan support and broad stakeholder acceptance.

Value-based insurance design (VBID) recognizes that traditional benefit structures from the 1960s were designed for acute-care episodes rather than today's population of chronically ill patients with multiple conditions. VBID eliminates cost-sharing for medications and services with high clinical value (diabetes medications, heart failure treatments, COPD therapies, hypertension management, lipid-lowering drugs) while maintaining or increasing cost-sharing for services with marginal clinical benefit. Research shows that eliminating cost-sharing for high-value services increases adherence without increasing overall spending, as reduced hospitalizations offset medication costs.

Value-based insurance design (VBID) aligns financial incentives with clinical value by removing cost-sharing for high-value services while maintaining or increasing cost-sharing for low-value services. High-value services are defined as those that are cost-effective (typically under $100,000-$250,000 per quality-adjusted life year) and improve patient outcomes. Low-value services include those identified by Choosing Wisely as commonly used but not useful. Implementation examples include Michigan's Focus on Diabetes program, which eliminated cost-sharing for diabetic patients' recommended medications and aligned disease management with financial incentives. Evidence shows lowering co-pays for high-value medications increases adherence and reduces adverse events. However, financing VBID requires either productivity gains or increased cost-sharing for low-value services, and challenges remain in identifying high/low value services, implementing IT systems, and educating patients to shop effectively.

Value-Based Insurance Design (VBID) is a healthcare financing approach developed at the University of Michigan that shifts from traditional 'one-size-fits-all' cost-sharing models to a system where patients pay less for high-value preventive and therapeutic services that improve health outcomes, and more for low-value or discretionary services; this approach incorporates clinical nuance—recognizing that the value of medical services varies based on the patient's specific condition, the provider's expertise, and the care setting—which has received bipartisan political support and was included in the Affordable Care Act, with ongoing efforts to expand it to Medicare.

The RAND study found that higher cost-sharing led to reduced healthcare utilization and spending. Participants in cost-sharing plans used less healthcare overall. However, this reduction affected both necessary and unnecessary care equally, as people are generally poor discriminators of what care is truly needed versus unneeded.

South Korea's medical cost structure shows that essential medical care (7.8% growth) and non-essential care (12-14% growth) have different cost trajectories. Physicians are incentivized to move from essential to non-essential care because the latter offers higher returns. This creates a situation where essential medical care is being sacrificed for higher returns. The system is described as having a fundamental incentive problem that drives physicians away from essential care.

A 1975 experiment tested whether cost-sharing affects healthcare utilization. One group had no cost-sharing (no co-pays), while another group had co-pays. Results showed that the no-cost-sharing group used healthcare services much more frequently, even for minor or unnecessary reasons. The co-payment group used healthcare only when they genuinely needed it. This demonstrates that cost-sharing helps reduce healthcare expenditures by preventing unnecessary utilization while still allowing access when truly needed.

Research demonstrates that even small cost-sharing requirements cause low-income sick patients to cut back on essential care and struggle to distinguish between essential and non-essential treatments. Canadian studies of elderly and low-income populations showed similar patterns with prescription drugs—patients weren't taking medications they needed, leading to emergency room visits and hospitalizations. This evidence suggests that insurance design must carefully balance cost-sharing incentives with access to necessary care.

The speaker argues that 'everything is an essential journey if you felt like you wanted to do it' and that 'you're an essential person because you're alive and we all need you.' She criticizes the distinction between essential and non-essential journeys, stating that wanting to 'dance naked on a podium on a beach' is just as essential as any other journey. She also criticizes the healthcare system, stating that 'no one is a hero' for using radiography equipment that 'should have been being used to save someone's grandfather.' She argues that people shouldn't be at the front of supermarket queues just because they have a 'socialized healthcare badge.'

The ACA addresses cost containment through preventative care—removing barriers to early intervention reduces reliance on expensive emergency room visits. The Medicare Part D doughnut hole, created under Bush administration cost-shifting, was closed through ACA provisions. Penalties for non-compliance are enforced through tax filings, similar to driver's license requirements. Young adults up to age 26 retain parental coverage, extending protection to those who would otherwise be uninsured. These provisions demonstrate how structural incentives can improve access while controlling long-term costs.

The Affordable Care Act (ACA), enacted 16 years ago, fundamentally transformed American healthcare by eliminating practices like rescission (cancelling coverage when people got sick), removing lifetime and annual coverage caps, banning discrimination against pre-existing conditions, and making preventive care free; however, recent policy actions including the elimination of ACA tax credits and proposed Medicaid cuts threaten to undermine these protections, forcing millions of Americans to choose between unaffordable premiums, reduced coverage through less generous plans, or losing coverage entirely, highlighting the critical importance of sustained advocacy to protect healthcare access for vulnerable populations.

The video addresses critical healthcare policy issues affecting millions of Americans. A constituent shares personal experience as a breast cancer survivor and pre-existing condition holder who relies on ACA protections to maintain health insurance coverage. The speaker acknowledges Project 2025's potential to eliminate or restructure the ACA, which would leave millions of Americans with pre-existing conditions uninsured. The discussion also covers intersex identity recognition, affirming that intersex individuals exist as a distinct population deserving acknowledgment and respect. Throughout, the speaker commits to ensuring safety net programs remain available for those who cannot obtain private insurance, balancing fiscal responsibility with protecting vulnerable populations. The presentation reveals tensions between healthcare access and budget constraints, illustrating how policy decisions impact real people's lives.

The U.S. Supreme Court is hearing a case challenging the constitutionality of a task force under the Affordable Care Act that recommends which preventive care treatments private insurers must cover without patient cost, with plaintiffs arguing the task force violates the Constitution's Appointments Clause requiring presidential nomination and Senate confirmation, while the Trump administration defends it as comprising 'inferior officers' removable by the Secretary of Health and Human Services; the ruling could impact access to preventive services including cancer screening, HIV-prevention medicine, and maternal counseling for approximately 150 million Americans with private insurance.

The speaker presents personal accounts of how the Affordable Care Act has protected vulnerable individuals. A constituent with a daughter diagnosed with juvenile diabetes at age 15 gained coverage without waiting periods or denials. Another constituent with chronic degenerative disc disease and back pain can continue receiving necessary pain management treatment including nerve ablation procedures. Without the ACA, these individuals would face bankruptcy, denial of care, and return to the fears and worries they experienced before the law.